Delivery Order SPE2DB22D3301-SPE2DB25FZ0GK
- Not listed
- The Defense Logistics Agency awarded a $12,329.16 delivery order to AmerisourceBergen Drug Corp for 28 capsules of Revlimid 5 mg on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Revlimid 10 mg capsules (100-count units) with a ceiling value of $52,575.49. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order valued at $51,681.12 to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete procurement action issued under...
- The Defense Logistics Agency awarded a $51,879.46 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Revlimid 5 mg capsules (100-count units). This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award utilizes no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The Defense Logistics Agency awarded a delivery order valued at approximately $25.8K to AmerisourceBergen Drug Corp for the supply of Revlimid 10 mg capsules (quantity: 28 units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $53,251.31 to AmerisourceBergen Drug Corp for the supply of Revlimid 15 mg capsules (100-count units) on July 24, 2025, with completion expected by August 14, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,329.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count) under a Firm Fixed Price contract with an ultimate completion date of September 3, 2025. This non-set-aside award was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $53,251.31 for Revlimid 15 mg capsules (100-count units) on August 28, 2025, with an ultimate completion date of September 19, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Revlimid 15 mg capsules (100-count units) with a ceiling value of $53,251.31. This firm fixed price delivery order, with a completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a $123,328 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will deliver 28 count bottles of the 10mg capsule formulation of Revlimid to a facility in Conshohocken, Pennsylvania by October 2, 2023. Revlimid is a thalidomide analogue approved for the treatment of multiple myeloma and myelodysplastic syndromes. This delivery order was issued against an existing DLA...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0GKDelivery Order
The Defense Logistics Agency awarded a $12,329.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 28-count bottles of Revlimid 5 mg capsules, with an ultimate completion date of September 23, 2025. This non-set-aside competitive award was issued on September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Revlimid is an immunomodulatory medication commonly used in the treatment of multiple myeloma and other hematologic malignancies within military and veteran healthcare systems. This delivery order represents a task issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion pharmaceutical prime vendor vehicle valued through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The firm's competitive award of this delivery order demonstrates its continued capability to fulfill federal medical procurement requirements for specialty pharmaceutical products essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/2/25 |